Summary
Updated Aug 31, 2026
Gary D. Glick is President and Chief Executive Officer of Odyssey Therapeutics, Inc. (ODTX). 1 SEC Form 4 filing on record, dated 12 May 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Gary D. Glick has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary D. Glick files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- TPG GP A, LLC - $25.00M of ODTX open-market activity in the last 12 months
- Nan (Ln) Li - $20.00M of ODTX open-market activity in the last 12 months
- Dimension Capital II, L.P. - $20.00M of ODTX open-market activity in the last 12 months
- SR ONE CAPITAL MANAGEMENT, LLC - $10.03M of ODTX open-market activity in the last 12 months
- Shelley Chu - $200K of ODTX open-market activity in the last 12 months
- Jeffrey M. Leiden - $100K of ODTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gary D. Glick?
Gary D. Glick is a corporate insider, tracked as President and Chief Executive Officer of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Gary D. Glick last file a Form 4?
The only primary Form 4 on record is dated 12 May 2026.
Where can I see all of Gary D. Glick's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gary D. Glick and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
